These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7910858)

  • 1. [Variable-regions of immunoglobulin H-chain genes encoding anti-TSH receptor antibodies].
    Matsuda F
    Nihon Rinsho; 1994 Apr; 52(4):1013-7. PubMed ID: 7910858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable regions of Ig heavy chain genes encoding antithyrotropin receptor antibodies of patients with Graves' disease.
    Shin EK; Akamizu T; Matsuda F; Sugawa H; Fujikura J; Mori T; Honjo T
    J Immunol; 1994 Feb; 152(3):1485-92. PubMed ID: 8301147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of stimulatory anti-thyrotropin receptor antibodies (TSAbs) involved in Graves' disease. Isolation and reconstruction of antibody genes, and production of monoclonal TSAbs.
    Akamizu T; Matsuda F; Okuda J; Li H; Kanda H; Watanabe T; Honjo T; Mori T
    J Immunol; 1996 Oct; 157(7):3148-52. PubMed ID: 8816426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
    Schott M; Minich WB; Willenberg HS; Papewalis C; Seissler J; Feldkamp J; Bergmann A; Scherbaum WA; Morgenthaler NG
    Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor.
    Watanabe Y; Tahara K; Hirai A; Tada H; Kohn LD; Amino N
    Thyroid; 1997 Feb; 7(1):13-9. PubMed ID: 9086564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a transgenic animal model of hyperthyroid Graves' disease.
    Kim-Saijo M; Akamizu T; Ikuta K; Iida Y; Ohmori K; Matsubara K; Matsuda Y; Suzuki M; Matsuda F; Nakao K
    Eur J Immunol; 2003 Sep; 33(9):2531-8. PubMed ID: 12938229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A majority of Ig H chain cDNA of normal human adult blood lymphocytes resembles cDNA for fetal Ig and natural autoantibodies.
    Huang C; Stollar BD
    J Immunol; 1993 Nov; 151(10):5290-300. PubMed ID: 8228225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
    Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
    Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
    Morgenthaler NG; Pampel I; Aust G; Seissler J; Scherbaum WA
    Horm Metab Res; 1998 Mar; 30(3):162-8. PubMed ID: 9566861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease.
    Hovens GC; Buiting AM; Karperien M; Ballieux BE; van der Pluijm G; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):429-35. PubMed ID: 16584516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of Epstein-Barr-virus-transformed lymphocytes producing IgG class monoclonal antibodies using a magnetic cell separator (MACS): preparation of thyroid-stimulating IgG antibodies from patients with Graves' disease.
    Li H; Akamizu T; Okuda J; Sugawa H; Matsuda F; Tsubata T; Mori T
    Biochem Biophys Res Commun; 1995 Feb; 207(3):985-93. PubMed ID: 7864905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline V genes encode viable motheaten mouse autoantibodies against thymocytes and red blood cells.
    Kasturi KN; Mayer R; Bona CA; Scott VE; Sidman CL
    J Immunol; 1990 Oct; 145(7):2304-11. PubMed ID: 2118932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of radioiodine on thyrotrophin receptor antibodies in Graves' disease.
    Aizawa Y; Yoshida K; Kaise N; Kaise K; Fukazawa H; Kiso Y; Mori K; Sayama N; Kikuchi K; Abe K
    Clin Endocrinol (Oxf); 1995 May; 42(5):517-22. PubMed ID: 7621571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human anti-thyroid peroxidase autoantibody repertoire in Graves' and Hashimoto's autoimmune thyroid diseases.
    Chardès T; Chapal N; Bresson D; Bès C; Giudicelli V; Lefranc MP; Péraldi-Roux S
    Immunogenetics; 2002 Jun; 54(3):141-57. PubMed ID: 12073143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal predictive criteria for neonatal overt thyrotoxicosis requiring treatment.
    Tamaki H; Amino N; Aozasa M; Mori M; Iwatani Y; Tachi J; Nose O; Tanizawa O; Miyai K
    Am J Perinatol; 1988 Apr; 5(2):152-8. PubMed ID: 2450549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity in the complementarity-determining region 3 (CDR3) of antibodies from mice with evolving anti-thyroid-stimulating hormone receptor antibody responses.
    Martinez O; Gangi E; Mordi D; Gupta S; Dorevitch S; Lefranc MP; Prabhakar BS
    Endocrinology; 2007 Feb; 148(2):752-61. PubMed ID: 17068139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of epitopes for TSH receptor autoantibodies using TSH receptor/LH-CG receptor chimeras].
    Tahara K; Yamamoto K; Tamura Y; Yoshida S
    Nihon Rinsho; 1994 Apr; 52(4):1031-6. PubMed ID: 7515118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human monoclonal striational autoantibodies isolated from thymic B lymphocytes of patients with myasthenia gravis use VH and VL gene segments associated with the autoimmune repertoire.
    Victor KD; Pascual V; Williams CL; Lennon VA; Capra JD
    Eur J Immunol; 1992 Sep; 22(9):2231-6. PubMed ID: 1516616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.